Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |